| 0 |
BLOOD HUMAN CHORIONIC GONADOTROPIN NEGATIVE |
1 |
0.5000 |
| 1 |
OVARIAN TORSION |
18 |
0.2169 |
| 2 |
LUTEINISING UNRUPTURED FOLLICLE SYNDROME |
1 |
0.2000 |
| 3 |
MALIGNANT HYDATIDIFORM MOLE |
1 |
0.1667 |
| 4 |
URINE DELTA AMINOLEVULINATE |
1 |
0.1429 |
| 5 |
FEMALE GENITAL TRACT TUBERCULOSIS |
1 |
0.1429 |
| 6 |
HETEROTOPIC PREGNANCY |
7 |
0.1111 |
| 7 |
OVARIAN NECROSIS |
7 |
0.1111 |
| 8 |
VARIANT CREUTZFELDT-JAKOB DISEASE |
1 |
0.1111 |
| 9 |
THERMOPHOBIA |
2 |
0.1053 |
| 10 |
CYSTOSARCOMA PHYLLODES |
1 |
0.1000 |
| 11 |
GONADOTROPHIN DEFICIENCY |
2 |
0.0741 |
| 12 |
BRAIN TERATOMA |
1 |
0.0714 |
| 13 |
MULTIPLE PREGNANCY |
10 |
0.0559 |
| 14 |
OVARIAN HYPERSTIMULATION SYNDROME |
130 |
0.0557 |
| 15 |
OVARIAN HAEMATOMA |
1 |
0.0556 |
| 16 |
SEX CHROMOSOME ABNORMALITY |
1 |
0.0476 |
| 17 |
THROMBIN-ANTITHROMBIN III COMPLEX INCREASED |
1 |
0.0476 |
| 18 |
PORPHYRINS URINE INCREASED |
1 |
0.0476 |
| 19 |
OPTIC NERVE SHEATH MENINGIOMA |
1 |
0.0455 |
| 20 |
URINE PORPHOBILINOGEN INCREASED |
1 |
0.0455 |
| 21 |
YERSINIA TEST POSITIVE |
1 |
0.0435 |
| 22 |
BLOOD PRESSURE SYSTOLIC INSPIRATORY DECREASED |
2 |
0.0426 |
| 23 |
PRADER-WILLI SYNDROME |
2 |
0.0392 |
| 24 |
BLOOD HUMAN CHORIONIC GONADOTROPIN DECREASED |
1 |
0.0357 |
| 25 |
OVARIAN RUPTURE |
4 |
0.0342 |
| 26 |
OVARIAN CYST TORSION |
2 |
0.0339 |
| 27 |
HYDROSALPINX |
3 |
0.0326 |
| 28 |
PERITONEAL HERNIA |
1 |
0.0323 |
| 29 |
VENA CAVA FILTER REMOVAL |
1 |
0.0294 |
| 30 |
OVARIAN ENLARGEMENT |
11 |
0.0287 |
| 31 |
GLIOSARCOMA |
1 |
0.0286 |
| 32 |
PERCUSSION TEST ABNORMAL |
1 |
0.0270 |
| 33 |
OBSTETRIC PROCEDURE COMPLICATION |
1 |
0.0270 |
| 34 |
ABORTION COMPLETE |
1 |
0.0270 |
| 35 |
FLAP NECROSIS |
1 |
0.0270 |
| 36 |
ABORTION SPONTANEOUS COMPLETE |
1 |
0.0256 |
| 37 |
ABORTED PREGNANCY |
1 |
0.0213 |
| 38 |
HIP SWELLING |
1 |
0.0208 |
| 39 |
HEPATOBLASTOMA |
2 |
0.0206 |
| 40 |
TUBAL RUPTURE |
1 |
0.0200 |
| 41 |
CIRCULATORY FAILURE NEONATAL |
1 |
0.0169 |
| 42 |
OVARIAN HAEMORRHAGE |
4 |
0.0169 |
| 43 |
SEPTUM PELLUCIDUM AGENESIS |
1 |
0.0167 |
| 44 |
CEREBRAL DYSGENESIS |
1 |
0.0167 |
| 45 |
DUODENAL ATRESIA |
2 |
0.0163 |
| 46 |
CEPHALO-PELVIC DISPROPORTION |
3 |
0.0150 |
| 47 |
BORDERLINE OVARIAN TUMOUR |
1 |
0.0149 |
| 48 |
NONINFECTIVE OOPHORITIS |
1 |
0.0149 |
| 49 |
GARDNERELLA INFECTION |
1 |
0.0145 |
| 50 |
NEONATAL RESPIRATORY ARREST |
2 |
0.0137 |
| 51 |
OLIGODIPSIA |
3 |
0.0128 |
| 52 |
INTRAPARTUM HAEMORRHAGE |
1 |
0.0125 |
| 53 |
DRUG EXPOSURE BEFORE PREGNANCY |
12 |
0.0118 |
| 54 |
UTERINE TENDERNESS |
1 |
0.0116 |
| 55 |
HAEMOCONCENTRATION |
2 |
0.0116 |
| 56 |
BREECH DELIVERY |
1 |
0.0109 |
| 57 |
TWIN PREGNANCY |
9 |
0.0107 |
| 58 |
EXCESSIVE EXERCISE |
1 |
0.0105 |
| 59 |
CONJOINED TWINS |
1 |
0.0101 |
| 60 |
ECTOPIC PREGNANCY |
31 |
0.0101 |
| 61 |
ABORTION THREATENED |
5 |
0.0100 |
| 62 |
OLIGOSPERMIA |
1 |
0.0097 |
| 63 |
ANOVULATORY CYCLE |
2 |
0.0097 |
| 64 |
PERIANAL ABSCESS |
1 |
0.0096 |
| 65 |
PROGESTERONE INCREASED |
1 |
0.0090 |
| 66 |
URETERIC INJURY |
1 |
0.0089 |
| 67 |
CHLAMYDIA TEST POSITIVE |
1 |
0.0088 |
| 68 |
OVULATION DISORDER |
1 |
0.0085 |
| 69 |
UTERINE HYPOTONUS |
1 |
0.0079 |
| 70 |
BLIGHTED OVUM |
3 |
0.0076 |
| 71 |
RETINITIS PIGMENTOSA |
2 |
0.0076 |
| 72 |
INTESTINAL MALROTATION |
2 |
0.0076 |
| 73 |
BREAKTHROUGH HAEMOLYSIS |
3 |
0.0075 |
| 74 |
UNWANTED PREGNANCY |
1 |
0.0073 |
| 75 |
APPLICATION SITE NODULE |
1 |
0.0073 |
| 76 |
MALIGNANT NEOPLASM OF AMPULLA OF VATER |
1 |
0.0072 |
| 77 |
DISSEMINATED COCCIDIOIDOMYCOSIS |
1 |
0.0071 |
| 78 |
HAEMORRHAGIC OVARIAN CYST |
4 |
0.0070 |
| 79 |
CREUTZFELDT-JAKOB DISEASE |
2 |
0.0069 |
| 80 |
RENAL ARTERY THROMBOSIS |
2 |
0.0065 |
| 81 |
CHROMOSOMAL DELETION |
1 |
0.0063 |
| 82 |
SALPINGITIS |
2 |
0.0063 |
| 83 |
INTESTINAL STRANGULATION |
1 |
0.0062 |
| 84 |
BASILAR ARTERY OCCLUSION |
1 |
0.0060 |
| 85 |
CRANIOPHARYNGIOMA |
2 |
0.0060 |
| 86 |
SELECTIVE ABORTION |
1 |
0.0057 |
| 87 |
PELVIC FLUID COLLECTION |
4 |
0.0057 |
| 88 |
BASILAR ARTERY THROMBOSIS |
1 |
0.0056 |
| 89 |
RUPTURED ECTOPIC PREGNANCY |
4 |
0.0052 |
| 90 |
PERITONEAL HAEMORRHAGE |
7 |
0.0050 |
| 91 |
PRODUCT CONTAMINATION WITH BODY FLUID |
1 |
0.0049 |
| 92 |
RETAINED PRODUCTS OF CONCEPTION |
1 |
0.0049 |
| 93 |
SITTING DISABILITY |
3 |
0.0049 |
| 94 |
GLUCOCORTICOID DEFICIENCY |
2 |
0.0047 |
| 95 |
PLACENTA ACCRETA |
1 |
0.0046 |
| 96 |
ALANINE AMINOTRANSFERASE |
1 |
0.0045 |
| 97 |
THROMBOSIS MESENTERIC VESSEL |
1 |
0.0044 |
| 98 |
RENAL CORTICAL NECROSIS |
1 |
0.0043 |
| 99 |
MYELOPROLIFERATIVE DISORDER |
1 |
0.0041 |
| 100 |
BLOOD LUTEINISING HORMONE INCREASED |
1 |
0.0041 |
| 101 |
BUDD-CHIARI SYNDROME |
1 |
0.0040 |
| 102 |
NEONATAL RESPIRATORY FAILURE |
2 |
0.0040 |
| 103 |
CONGENITAL HYDROCEPHALUS |
2 |
0.0039 |
| 104 |
THERAPEUTIC PRODUCT CONTAMINATION |
1 |
0.0039 |
| 105 |
CEREBRAL CALCIFICATION |
1 |
0.0037 |
| 106 |
ANTITHROMBIN III DECREASED |
1 |
0.0037 |
| 107 |
PSEUDOLYMPHOMA |
2 |
0.0036 |
| 108 |
CAROTID ARTERY THROMBOSIS |
3 |
0.0035 |
| 109 |
SPLENIC HAEMATOMA |
1 |
0.0035 |
| 110 |
HAEMORRHAGIC ASCITES |
1 |
0.0035 |
| 111 |
CARDIO-RESPIRATORY DISTRESS |
1 |
0.0035 |
| 112 |
FIBRIN DEGRADATION PRODUCTS INCREASED |
1 |
0.0034 |
| 113 |
OESTRADIOL INCREASED |
1 |
0.0033 |
| 114 |
SEMEN DISCOLOURATION |
1 |
0.0033 |
| 115 |
INFREQUENT BOWEL MOVEMENTS |
8 |
0.0032 |
| 116 |
OESOPHAGEAL ATRESIA |
2 |
0.0032 |
| 117 |
FOETAL CARDIAC DISORDER |
1 |
0.0032 |
| 118 |
ANOMALY OF EXTERNAL EAR CONGENITAL |
1 |
0.0032 |
| 119 |
ADNEXAL TORSION |
1 |
0.0032 |
| 120 |
ABORTION MISSED |
4 |
0.0031 |
| 121 |
OESTRADIOL DECREASED |
1 |
0.0031 |
| 122 |
TYMPANIC MEMBRANE DISORDER |
1 |
0.0031 |
| 123 |
NEONATAL RESPIRATORY DEPRESSION |
1 |
0.0030 |
| 124 |
VASCULAR STENOSIS |
1 |
0.0029 |
| 125 |
NEONATAL INFECTION |
1 |
0.0029 |
| 126 |
ACUTE DISSEMINATED ENCEPHALOMYELITIS |
1 |
0.0029 |
| 127 |
CERVIX DISORDER |
2 |
0.0028 |
| 128 |
SINGLE UMBILICAL ARTERY |
1 |
0.0027 |
| 129 |
AXILLARY VEIN THROMBOSIS |
1 |
0.0027 |
| 130 |
HYPEREMESIS GRAVIDARUM |
1 |
0.0026 |
| 131 |
PRODUCT BARCODE ISSUE |
1 |
0.0026 |
| 132 |
INFERTILITY FEMALE |
4 |
0.0026 |
| 133 |
PLACENTA PRAEVIA |
2 |
0.0025 |
| 134 |
VULVAL OEDEMA |
1 |
0.0025 |
| 135 |
INTRA-UTERINE DEATH |
4 |
0.0025 |
| 136 |
HYDROTHORAX |
2 |
0.0024 |
| 137 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED |
1 |
0.0024 |
| 138 |
AMAUROSIS |
2 |
0.0024 |
| 139 |
MELANOMA RECURRENT |
1 |
0.0024 |
| 140 |
ABDOMINAL CAVITY DRAINAGE |
1 |
0.0024 |
| 141 |
PYLORIC STENOSIS |
2 |
0.0024 |
| 142 |
OVARIAN CYST RUPTURED |
3 |
0.0023 |
| 143 |
THREATENED LABOUR |
1 |
0.0023 |
| 144 |
HALLUCINATION, OLFACTORY |
1 |
0.0023 |
| 145 |
ADRENOCORTICOTROPIC HORMONE DEFICIENCY |
2 |
0.0023 |
| 146 |
CONGENITAL MUSCULOSKELETAL ANOMALY |
1 |
0.0023 |
| 147 |
JUGULAR VEIN THROMBOSIS |
4 |
0.0022 |
| 148 |
PELVIC INFECTION |
1 |
0.0022 |
| 149 |
PREGNANCY TEST FALSE POSITIVE |
1 |
0.0021 |
| 150 |
NEUROLOGICAL EXAMINATION ABNORMAL |
1 |
0.0021 |
| 151 |
BASEDOW'S DISEASE |
1 |
0.0021 |
| 152 |
PREMATURE RUPTURE OF MEMBRANES |
5 |
0.0021 |
| 153 |
INTRAVENTRICULAR HAEMORRHAGE NEONATAL |
1 |
0.0021 |
| 154 |
DRAINAGE |
1 |
0.0020 |
| 155 |
HYPOGONADISM |
2 |
0.0020 |
| 156 |
CERVICAL INCOMPETENCE |
1 |
0.0020 |
| 157 |
CEREBRAL ARTERY THROMBOSIS |
1 |
0.0019 |
| 158 |
UTERINE CONTRACTIONS DURING PREGNANCY |
2 |
0.0019 |
| 159 |
POLYCYSTIC OVARIES |
3 |
0.0019 |
| 160 |
FEEDING DISORDER NEONATAL |
2 |
0.0019 |
| 161 |
TRANSVERSE SINUS THROMBOSIS |
1 |
0.0019 |
| 162 |
TUMOUR NECROSIS |
2 |
0.0019 |
| 163 |
GINGIVAL DISCOLOURATION |
1 |
0.0019 |
| 164 |
MORNING SICKNESS |
1 |
0.0018 |
| 165 |
THROMBOCYTHAEMIA |
1 |
0.0018 |
| 166 |
BLOOD GROWTH HORMONE INCREASED |
1 |
0.0018 |
| 167 |
PORTAL HYPERTENSIVE GASTROPATHY |
1 |
0.0018 |
| 168 |
HAEMATOCRIT INCREASED |
4 |
0.0018 |
| 169 |
EJECTION FRACTION |
1 |
0.0017 |
| 170 |
BLOOD OESTROGEN INCREASED |
1 |
0.0017 |
| 171 |
OXYGEN CONSUMPTION DECREASED |
1 |
0.0017 |
| 172 |
CAESAREAN SECTION |
19 |
0.0016 |
| 173 |
BLOOD OSMOLARITY DECREASED |
1 |
0.0016 |
| 174 |
BREECH PRESENTATION |
2 |
0.0016 |
| 175 |
HYPOPROTEINAEMIA |
3 |
0.0016 |
| 176 |
HYPERCOAGULATION |
3 |
0.0016 |
| 177 |
PANCREATIC NEUROENDOCRINE TUMOUR |
1 |
0.0016 |
| 178 |
COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS |
1 |
0.0015 |
| 179 |
EFFUSION |
2 |
0.0015 |
| 180 |
SURGICAL PROCEDURE REPEATED |
1 |
0.0015 |
| 181 |
HAEMORRHAGIC CEREBRAL INFARCTION |
1 |
0.0014 |
| 182 |
MULTIPLE CONGENITAL ABNORMALITIES |
2 |
0.0014 |
| 183 |
INFUSION SITE BRUISING |
3 |
0.0014 |
| 184 |
RENAL INFARCT |
2 |
0.0014 |
| 185 |
WITHDRAWAL BLEED |
1 |
0.0014 |
| 186 |
LEGAL PROBLEM |
1 |
0.0014 |
| 187 |
CEREBRAL VASOCONSTRICTION |
1 |
0.0014 |
| 188 |
COMPLICATION OF PREGNANCY |
1 |
0.0013 |
| 189 |
OVARIAN NEOPLASM |
1 |
0.0013 |
| 190 |
PULMONARY ARTERY THROMBOSIS |
1 |
0.0013 |
| 191 |
BLOOD FIBRINOGEN INCREASED |
1 |
0.0013 |
| 192 |
RETROGRADE EJACULATION |
1 |
0.0013 |
| 193 |
INTRA-ABDOMINAL HAEMORRHAGE |
3 |
0.0013 |
| 194 |
SUPERIOR SAGITTAL SINUS THROMBOSIS |
1 |
0.0013 |
| 195 |
CONGENITAL CYSTIC KIDNEY DISEASE |
1 |
0.0012 |
| 196 |
CORONARY ARTERY DISSECTION |
1 |
0.0012 |
| 197 |
EOSINOPHILIC PNEUMONIA ACUTE |
1 |
0.0012 |
| 198 |
HYPOPITUITARISM |
2 |
0.0011 |
| 199 |
TESTICULAR ATROPHY |
1 |
0.0011 |
| 200 |
HUMAN CHORIONIC GONADOTROPIN INCREASED |
1 |
0.0011 |
| 201 |
DRUG EXPOSURE DURING PREGNANCY |
37 |
0.0011 |
| 202 |
EXTENSOR PLANTAR RESPONSE |
1 |
0.0011 |
| 203 |
HAEMOCHROMATOSIS |
1 |
0.0011 |
| 204 |
OVARIAN DISORDER |
1 |
0.0011 |
| 205 |
CEREBRAL THROMBOSIS |
3 |
0.0011 |
| 206 |
ASCITES |
31 |
0.0011 |
| 207 |
ABORTION |
3 |
0.0010 |
| 208 |
CONTINUOUS HAEMODIAFILTRATION |
1 |
0.0010 |
| 209 |
HEMIANOPIA |
1 |
0.0010 |
| 210 |
MESENTERIC VEIN THROMBOSIS |
1 |
0.0010 |
| 211 |
THYROIDITIS |
3 |
0.0010 |
| 212 |
BRAIN HYPOXIA |
1 |
0.0010 |
| 213 |
AUTISM |
1 |
0.0010 |
| 214 |
BODY TEMPERATURE FLUCTUATION |
2 |
0.0010 |
| 215 |
HYPOPERFUSION |
1 |
0.0010 |
| 216 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
2 |
0.0009 |
| 217 |
SMALL INTESTINAL STENOSIS |
1 |
0.0009 |
| 218 |
INTRACRANIAL VENOUS SINUS THROMBOSIS |
1 |
0.0009 |
| 219 |
CEREBRAL ARTERY OCCLUSION |
1 |
0.0009 |
| 220 |
DRUG EXPOSURE VIA BREAST MILK |
1 |
0.0009 |
| 221 |
BIPOLAR I DISORDER |
2 |
0.0009 |
| 222 |
CRYPTORCHISM |
1 |
0.0009 |
| 223 |
PREMATURE LABOUR |
5 |
0.0009 |
| 224 |
OESTROGEN RECEPTOR ASSAY POSITIVE |
1 |
0.0009 |
| 225 |
LIGAMENT INJURY |
1 |
0.0009 |
| 226 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
6 |
0.0009 |
| 227 |
ARTERIAL HAEMORRHAGE |
1 |
0.0009 |
| 228 |
CEREBRAL VENTRICLE DILATATION |
1 |
0.0009 |
| 229 |
ABORTION INDUCED |
8 |
0.0008 |
| 230 |
PREGNANCY |
17 |
0.0008 |
| 231 |
STREPTOCOCCAL SEPSIS |
1 |
0.0008 |
| 232 |
PRODUCT CONTAMINATION MICROBIAL |
1 |
0.0008 |
| 233 |
ENCEPHALITIS VIRAL |
1 |
0.0008 |
| 234 |
CEREBRAL ARTERY EMBOLISM |
1 |
0.0008 |
| 235 |
OLIGURIA |
5 |
0.0008 |
| 236 |
TRISOMY 21 |
1 |
0.0008 |
| 237 |
RETINAL ARTERY OCCLUSION |
2 |
0.0008 |
| 238 |
NECROTISING COLITIS |
1 |
0.0008 |
| 239 |
MATERNAL DRUGS AFFECTING FOETUS |
6 |
0.0008 |
| 240 |
ADNEXA UTERI PAIN |
1 |
0.0008 |
| 241 |
MICROCEPHALY |
1 |
0.0008 |
| 242 |
APGAR SCORE LOW |
1 |
0.0008 |
| 243 |
IATROGENIC INJURY |
1 |
0.0008 |
| 244 |
RETINAL DISORDER |
2 |
0.0008 |
| 245 |
EXPOSURE VIA FATHER |
1 |
0.0008 |
| 246 |
PATENT DUCTUS ARTERIOSUS |
3 |
0.0008 |
| 247 |
DEATH NEONATAL |
1 |
0.0007 |
| 248 |
MYELITIS TRANSVERSE |
1 |
0.0007 |
| 249 |
INSULIN-LIKE GROWTH FACTOR INCREASED |
1 |
0.0007 |
| 250 |
PELVIC VENOUS THROMBOSIS |
1 |
0.0007 |
| 251 |
PORPHYRIA ACUTE |
1 |
0.0007 |
| 252 |
INVESTIGATION ABNORMAL |
1 |
0.0007 |
| 253 |
ESCHERICHIA SEPSIS |
2 |
0.0007 |
| 254 |
MUTISM |
1 |
0.0007 |
| 255 |
ACUTE ABDOMEN |
1 |
0.0007 |
| 256 |
BRAIN HERNIATION |
2 |
0.0007 |
| 257 |
HAEMORRHAGIC TRANSFORMATION STROKE |
1 |
0.0007 |
| 258 |
ADHESION |
1 |
0.0007 |
| 259 |
PARAINFLUENZAE VIRUS INFECTION |
1 |
0.0007 |
| 260 |
HYPOTONIA NEONATAL |
1 |
0.0006 |
| 261 |
TESTICULAR PAIN |
2 |
0.0006 |
| 262 |
HYPOVOLAEMIC SHOCK |
3 |
0.0006 |
| 263 |
COLON CANCER METASTATIC |
1 |
0.0006 |
| 264 |
POOR QUALITY DRUG ADMINISTERED |
4 |
0.0006 |
| 265 |
OPTIC ATROPHY |
1 |
0.0006 |
| 266 |
INJECTION RELATED REACTION |
1 |
0.0006 |
| 267 |
SMALL FOR DATES BABY |
3 |
0.0006 |
| 268 |
GAZE PALSY |
1 |
0.0006 |
| 269 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 270 |
PUPIL FIXED |
1 |
0.0006 |
| 271 |
ABORTION SPONTANEOUS |
23 |
0.0006 |
| 272 |
CEREBRAL VENOUS THROMBOSIS |
1 |
0.0006 |
| 273 |
VULVOVAGINAL SWELLING |
1 |
0.0005 |
| 274 |
CEREBROSPINAL FLUID LEAKAGE |
1 |
0.0005 |
| 275 |
PUPILLARY REFLEX IMPAIRED |
1 |
0.0005 |
| 276 |
INTRACRANIAL PRESSURE INCREASED |
3 |
0.0005 |
| 277 |
ABORTION INCOMPLETE |
1 |
0.0005 |
| 278 |
PROTEIN TOTAL DECREASED |
2 |
0.0005 |
| 279 |
ARTERIAL THROMBOSIS |
1 |
0.0005 |
| 280 |
HYPERTRIGLYCERIDAEMIA |
3 |
0.0005 |
| 281 |
VENOUS THROMBOSIS |
2 |
0.0005 |
| 282 |
OVARIAN CYST |
5 |
0.0005 |
| 283 |
RENAL HAEMORRHAGE |
1 |
0.0005 |
| 284 |
QUADRIPLEGIA |
1 |
0.0005 |
| 285 |
INTESTINAL STENOSIS |
2 |
0.0005 |
| 286 |
OPTIC NEUROPATHY |
1 |
0.0005 |
| 287 |
LYMPHOCYTOSIS |
1 |
0.0005 |
| 288 |
SPINAL COLUMN INJURY |
1 |
0.0004 |
| 289 |
INFECTIOUS MONONUCLEOSIS |
1 |
0.0004 |
| 290 |
HAEMOGLOBIN INCREASED |
2 |
0.0004 |
| 291 |
UTERINE DISORDER |
1 |
0.0004 |
| 292 |
COLITIS MICROSCOPIC |
2 |
0.0004 |
| 293 |
CARDIAC TAMPONADE |
2 |
0.0004 |
| 294 |
VARICELLA |
1 |
0.0004 |
| 295 |
GASTROINTESTINAL OBSTRUCTION |
1 |
0.0004 |
| 296 |
PAINFUL RESPIRATION |
1 |
0.0004 |
| 297 |
LYMPHADENITIS |
1 |
0.0004 |
| 298 |
BREATH SOUNDS ABNORMAL |
2 |
0.0004 |
| 299 |
BREAST TENDERNESS |
3 |
0.0004 |
| 300 |
PLEURAL EFFUSION |
24 |
0.0004 |
| 301 |
HOSTILITY |
1 |
0.0004 |
| 302 |
LACTOSE INTOLERANCE |
1 |
0.0004 |
| 303 |
DISSEMINATED TUBERCULOSIS |
1 |
0.0004 |
| 304 |
HAEMOLYSIS |
3 |
0.0004 |
| 305 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 306 |
ANGIONEUROTIC OEDEMA |
1 |
0.0004 |
| 307 |
AREFLEXIA |
1 |
0.0004 |
| 308 |
ABDOMINAL RIGIDITY |
1 |
0.0004 |
| 309 |
HYDROCEPHALUS |
2 |
0.0004 |
| 310 |
RED BLOOD CELL COUNT INCREASED |
1 |
0.0004 |
| 311 |
INFUSION SITE ERYTHEMA |
3 |
0.0004 |
| 312 |
DISSEMINATED INTRAVASCULAR COAGULATION |
5 |
0.0004 |
| 313 |
GENERALISED ERYTHEMA |
2 |
0.0004 |
| 314 |
VISUAL DISTURBANCE |
2 |
0.0003 |
| 315 |
RETINAL VEIN OCCLUSION |
1 |
0.0003 |
| 316 |
METABOLIC DISORDER |
2 |
0.0003 |
| 317 |
URINE OUTPUT DECREASED |
3 |
0.0003 |
| 318 |
PURPURA |
3 |
0.0003 |
| 319 |
CEREBROVASCULAR DISORDER |
1 |
0.0003 |
| 320 |
VARICES OESOPHAGEAL |
1 |
0.0003 |
| 321 |
PELVIC PAIN |
6 |
0.0003 |
| 322 |
ISCHAEMIC CARDIOMYOPATHY |
1 |
0.0003 |
| 323 |
GENITAL HAEMORRHAGE |
4 |
0.0003 |
| 324 |
OEDEMA MOUTH |
1 |
0.0003 |
| 325 |
BREAST ENLARGEMENT |
1 |
0.0003 |
| 326 |
OTITIS MEDIA |
1 |
0.0003 |
| 327 |
CYTOLYTIC HEPATITIS |
1 |
0.0003 |
| 328 |
LYME DISEASE |
1 |
0.0003 |
| 329 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 330 |
DIFFICULTY IN WALKING |
1 |
0.0003 |
| 331 |
PRIAPISM |
1 |
0.0003 |
| 332 |
MASS |
4 |
0.0003 |
| 333 |
EMBOLIC STROKE |
1 |
0.0003 |
| 334 |
HAEMORRHAGE SUBCUTANEOUS |
1 |
0.0003 |
| 335 |
VISUAL FIELD DEFECT |
2 |
0.0003 |
| 336 |
VENTRICULAR ARRHYTHMIA |
1 |
0.0003 |
| 337 |
HYPOMANIA |
1 |
0.0003 |
| 338 |
PHARMACEUTICAL PRODUCT COMPLAINT |
7 |
0.0003 |
| 339 |
PULMONARY MASS |
4 |
0.0003 |
| 340 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
1 |
0.0003 |
| 341 |
GINGIVAL DISORDER |
1 |
0.0003 |
| 342 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
1 |
0.0003 |
| 343 |
HYPOALBUMINAEMIA |
2 |
0.0003 |
| 344 |
DIVERTICULITIS |
7 |
0.0003 |
| 345 |
BLOOD ALBUMIN DECREASED |
2 |
0.0003 |
| 346 |
LOW BIRTH WEIGHT BABY |
2 |
0.0003 |
| 347 |
CANDIDIASIS |
1 |
0.0002 |
| 348 |
CEREBRAL INFARCTION |
6 |
0.0002 |
| 349 |
GOITRE |
1 |
0.0002 |
| 350 |
ESCHERICHIA INFECTION |
2 |
0.0002 |
| 351 |
PERITONITIS |
5 |
0.0002 |
| 352 |
GASTROINTESTINAL PERFORATION |
1 |
0.0002 |
| 353 |
ABDOMINAL DISTENSION |
25 |
0.0002 |
| 354 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 355 |
PREMATURE BABY |
7 |
0.0002 |
| 356 |
CHAPPED LIPS |
1 |
0.0002 |
| 357 |
IMMUNE SYSTEM DISORDER |
3 |
0.0002 |
| 358 |
PHYSICAL DISABILITY |
1 |
0.0002 |
| 359 |
GRAND MAL CONVULSION |
2 |
0.0002 |
| 360 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 361 |
LACERATION |
2 |
0.0002 |
| 362 |
PRE-ECLAMPSIA |
1 |
0.0002 |
| 363 |
GESTATIONAL DIABETES |
1 |
0.0002 |
| 364 |
ENDOMETRIOSIS |
1 |
0.0002 |
| 365 |
SUBCUTANEOUS ABSCESS |
1 |
0.0002 |
| 366 |
TUMOUR MARKER INCREASED |
1 |
0.0002 |
| 367 |
AFFECT LABILITY |
2 |
0.0002 |
| 368 |
HYPERTHYROIDISM |
3 |
0.0002 |
| 369 |
STILLBIRTH |
1 |
0.0002 |
| 370 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 371 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 372 |
RENAL CELL CARCINOMA |
1 |
0.0002 |
| 373 |
HYPOTONIA |
2 |
0.0002 |
| 374 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 375 |
DYSLIPIDAEMIA |
1 |
0.0002 |
| 376 |
SUBARACHNOID HAEMORRHAGE |
2 |
0.0002 |
| 377 |
THYROID DISORDER |
3 |
0.0002 |
| 378 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 379 |
VARICOSE VEIN |
1 |
0.0002 |
| 380 |
FOETAL DEATH |
1 |
0.0002 |
| 381 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 382 |
PETECHIAE |
2 |
0.0002 |
| 383 |
UNINTENDED PREGNANCY |
2 |
0.0002 |
| 384 |
CATATONIA |
1 |
0.0002 |
| 385 |
SENSITIVITY TO WEATHER CHANGE |
1 |
0.0002 |
| 386 |
SERUM FERRITIN INCREASED |
1 |
0.0002 |
| 387 |
NYSTAGMUS |
1 |
0.0002 |
| 388 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 389 |
DRUG EFFECT DECREASED |
10 |
0.0002 |
| 390 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 391 |
MANIA |
3 |
0.0002 |
| 392 |
NECROSIS |
1 |
0.0002 |
| 393 |
FEELING COLD |
5 |
0.0002 |
| 394 |
PULMONARY ALVEOLAR HAEMORRHAGE |
1 |
0.0002 |
| 395 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 396 |
CIRCULATORY COLLAPSE |
3 |
0.0002 |
| 397 |
IMPAIRED DRIVING ABILITY |
2 |
0.0002 |
| 398 |
NEUROLOGICAL SYMPTOM |
1 |
0.0002 |
| 399 |
SKIN WARM |
1 |
0.0002 |
| 400 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 401 |
SPLENOMEGALY |
2 |
0.0002 |
| 402 |
URINE ODOUR ABNORMAL |
1 |
0.0002 |
| 403 |
BACTERAEMIA |
2 |
0.0002 |
| 404 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 405 |
TENSION |
1 |
0.0002 |
| 406 |
DRUG ABUSER |
1 |
0.0002 |
| 407 |
DRUG DIVERSION |
1 |
0.0002 |
| 408 |
VAGINAL HAEMORRHAGE |
7 |
0.0002 |
| 409 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 410 |
BLOOD SODIUM DECREASED |
3 |
0.0002 |
| 411 |
BRAIN OEDEMA |
2 |
0.0002 |
| 412 |
MUSCLE ATROPHY |
2 |
0.0002 |
| 413 |
INJECTION SITE IRRITATION |
2 |
0.0002 |
| 414 |
WHITE BLOOD CELL COUNT INCREASED |
6 |
0.0002 |
| 415 |
MYDRIASIS |
2 |
0.0002 |
| 416 |
UNRESPONSIVE TO STIMULI |
4 |
0.0002 |
| 417 |
BREAST CANCER STAGE III |
1 |
0.0002 |
| 418 |
DEEP VEIN THROMBOSIS |
10 |
0.0002 |
| 419 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 420 |
HAEMATOCRIT DECREASED |
3 |
0.0002 |
| 421 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 422 |
JAUNDICE |
4 |
0.0001 |
| 423 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 424 |
UVEITIS |
2 |
0.0001 |
| 425 |
TACHYPNOEA |
2 |
0.0001 |
| 426 |
PALLOR |
4 |
0.0001 |
| 427 |
FEELING HOT |
9 |
0.0001 |
| 428 |
BLOOD TESTOSTERONE DECREASED |
1 |
0.0001 |
| 429 |
NEPHROTIC SYNDROME |
1 |
0.0001 |
| 430 |
METASTASIS |
1 |
0.0001 |
| 431 |
TONGUE DISORDER |
1 |
0.0001 |
| 432 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 433 |
ORAL DISORDER |
1 |
0.0001 |
| 434 |
DUODENAL ULCER PERFORATION |
1 |
0.0001 |
| 435 |
PANCREATITIS ACUTE |
3 |
0.0001 |
| 436 |
PAROSMIA |
1 |
0.0001 |
| 437 |
HYPERTHERMIA |
1 |
0.0001 |
| 438 |
PERICARDIAL EFFUSION |
3 |
0.0001 |
| 439 |
EMOTIONAL DISORDER |
4 |
0.0001 |
| 440 |
CONGENITAL ANOMALY |
1 |
0.0001 |
| 441 |
THERAPY PARTIAL RESPONDER |
2 |
0.0001 |
| 442 |
BASAL CELL CARCINOMA |
2 |
0.0001 |
| 443 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 444 |
PULMONARY EMBOLISM |
12 |
0.0001 |
| 445 |
FURUNCLE |
1 |
0.0001 |
| 446 |
PREMATURE DELIVERY |
2 |
0.0001 |
| 447 |
BLOOD DISORDER |
1 |
0.0001 |
| 448 |
ABNORMAL FAECES |
1 |
0.0001 |
| 449 |
HAIR DISORDER |
1 |
0.0001 |
| 450 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 451 |
MUSCLE INJURY |
1 |
0.0001 |
| 452 |
EMBOLISM |
1 |
0.0001 |
| 453 |
HEMIPLEGIA |
1 |
0.0001 |
| 454 |
BREAST CANCER STAGE II |
1 |
0.0001 |
| 455 |
LIVE BIRTH |
1 |
0.0001 |
| 456 |
HAEMODIALYSIS |
1 |
0.0001 |
| 457 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 458 |
INADEQUATE ANALGESIA |
1 |
0.0001 |
| 459 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 460 |
INFLAMMATION |
6 |
0.0001 |
| 461 |
GROIN PAIN |
1 |
0.0001 |
| 462 |
LYMPHADENOPATHY |
4 |
0.0001 |
| 463 |
ASPARTATE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 464 |
MATERNAL EXPOSURE DURING PREGNANCY |
10 |
0.0001 |
| 465 |
BLOOD BILIRUBIN INCREASED |
3 |
0.0001 |
| 466 |
CRYING |
4 |
0.0001 |
| 467 |
OPTIC NEURITIS |
1 |
0.0001 |
| 468 |
PATHOGEN RESISTANCE |
1 |
0.0001 |
| 469 |
OVARIAN CANCER |
1 |
0.0001 |
| 470 |
APPENDICITIS |
1 |
0.0001 |
| 471 |
FLANK PAIN |
1 |
0.0001 |
| 472 |
HYPONATRAEMIA |
6 |
0.0001 |
| 473 |
LEUKAEMIA |
1 |
0.0001 |
| 474 |
COMA |
5 |
0.0001 |
| 475 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 476 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 477 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 478 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 479 |
HEPATOMEGALY |
1 |
0.0001 |
| 480 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
4 |
0.0001 |
| 481 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 482 |
SPINAL FRACTURE |
2 |
0.0001 |
| 483 |
THROMBOSIS |
8 |
0.0001 |
| 484 |
ALANINE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 485 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
1 |
0.0001 |
| 486 |
PRODUCT PREPARATION ERROR |
2 |
0.0001 |
| 487 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 488 |
TENDERNESS |
1 |
0.0001 |
| 489 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 490 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 491 |
ABDOMINAL PAIN |
21 |
0.0001 |
| 492 |
NERVE INJURY |
1 |
0.0001 |
| 493 |
METASTASES TO LUNG |
1 |
0.0001 |
| 494 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 495 |
FIBROMYALGIA |
2 |
0.0001 |
| 496 |
NEURALGIA |
2 |
0.0001 |
| 497 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 498 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 499 |
HAEMOGLOBIN DECREASED |
8 |
0.0001 |
| 500 |
HIATUS HERNIA |
1 |
0.0001 |
| 501 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 502 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 503 |
ADVERSE REACTION |
1 |
0.0001 |
| 504 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 505 |
DISTURBANCE IN ATTENTION |
4 |
0.0001 |
| 506 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 507 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 508 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 509 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 510 |
HUNGER |
1 |
0.0001 |
| 511 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 512 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 513 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 514 |
BRONCHOSPASM |
1 |
0.0001 |
| 515 |
PARALYSIS |
1 |
0.0001 |
| 516 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 517 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 518 |
RESPIRATORY FAILURE |
5 |
0.0001 |
| 519 |
APATHY |
1 |
0.0001 |
| 520 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 521 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 522 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 523 |
INSURANCE ISSUE |
1 |
0.0001 |
| 524 |
NERVOUS SYSTEM DISORDER |
2 |
0.0001 |
| 525 |
MENINGIOMA |
1 |
0.0001 |
| 526 |
CYANOSIS |
1 |
0.0001 |
| 527 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 528 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 529 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 530 |
FUNGAL INFECTION |
2 |
0.0001 |
| 531 |
URINARY RETENTION |
2 |
0.0001 |
| 532 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 533 |
FACE OEDEMA |
1 |
0.0001 |
| 534 |
METRORRHAGIA |
1 |
0.0001 |
| 535 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 536 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 537 |
DELIRIUM |
2 |
0.0001 |
| 538 |
METASTASES TO LIVER |
1 |
0.0001 |
| 539 |
PANCREATITIS |
3 |
0.0001 |
| 540 |
BRADYCARDIA |
3 |
0.0001 |
| 541 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 542 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 543 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 544 |
HYPERGLYCAEMIA |
2 |
0.0001 |
| 545 |
OROPHARYNGEAL PAIN |
5 |
0.0001 |
| 546 |
NECK PAIN |
3 |
0.0001 |
| 547 |
SWELLING |
5 |
0.0001 |
| 548 |
DYSARTHRIA |
2 |
0.0001 |
| 549 |
DEHYDRATION |
7 |
0.0001 |
| 550 |
CONVULSION |
3 |
0.0001 |
| 551 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 552 |
ACUTE KIDNEY INJURY |
8 |
0.0001 |
| 553 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 554 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 555 |
ORAL HERPES |
1 |
0.0001 |
| 556 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 557 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 558 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 559 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 560 |
PSORIATIC ARTHROPATHY |
2 |
0.0000 |
| 561 |
FOETAL EXPOSURE DURING PREGNANCY |
4 |
0.0000 |
| 562 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 563 |
RIB FRACTURE |
1 |
0.0000 |
| 564 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 565 |
POLLAKIURIA |
2 |
0.0000 |
| 566 |
DYSPNOEA |
27 |
0.0000 |
| 567 |
DECREASED APPETITE |
11 |
0.0000 |
| 568 |
ANAEMIA |
9 |
0.0000 |
| 569 |
OSTEOARTHRITIS |
2 |
0.0000 |
| 570 |
RENAL FAILURE ACUTE |
2 |
0.0000 |
| 571 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 572 |
HYPERHIDROSIS |
6 |
0.0000 |
| 573 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 574 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 575 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 576 |
TACHYCARDIA |
4 |
0.0000 |
| 577 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 578 |
PRODUCT USE IN UNAPPROVED INDICATION |
11 |
0.0000 |
| 579 |
CHROMATURIA |
1 |
0.0000 |
| 580 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 581 |
ERYTHEMA |
9 |
0.0000 |
| 582 |
SHOCK |
1 |
0.0000 |
| 583 |
RENAL DISORDER |
2 |
0.0000 |
| 584 |
ARRHYTHMIA |
2 |
0.0000 |
| 585 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 586 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 587 |
HEADACHE |
26 |
0.0000 |
| 588 |
OEDEMA PERIPHERAL |
5 |
0.0000 |
| 589 |
AGITATION |
3 |
0.0000 |
| 590 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 591 |
ABASIA |
1 |
0.0000 |
| 592 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 593 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 594 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 595 |
FLUSHING |
4 |
0.0000 |
| 596 |
HEPATITIS |
1 |
0.0000 |
| 597 |
PAIN |
24 |
0.0000 |
| 598 |
LOSS OF CONSCIOUSNESS |
5 |
0.0000 |
| 599 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 600 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 601 |
BACK PAIN |
9 |
0.0000 |
| 602 |
OFF LABEL USE |
33 |
0.0000 |
| 603 |
EAR INFECTION |
1 |
0.0000 |
| 604 |
INSOMNIA |
10 |
0.0000 |
| 605 |
BREAST CANCER FEMALE |
1 |
0.0000 |
| 606 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 607 |
PRODUCT USE ISSUE |
7 |
0.0000 |
| 608 |
INFLUENZA LIKE ILLNESS |
3 |
0.0000 |
| 609 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 610 |
HAEMOPTYSIS |
1 |
0.0000 |
| 611 |
DEMENTIA |
1 |
0.0000 |
| 612 |
WEIGHT INCREASED |
8 |
0.0000 |
| 613 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 614 |
EYE PAIN |
2 |
0.0000 |
| 615 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 616 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 617 |
HYPERSOMNIA |
1 |
0.0000 |
| 618 |
SOMNOLENCE |
7 |
0.0000 |
| 619 |
LETHARGY |
2 |
0.0000 |
| 620 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 621 |
NAUSEA |
27 |
0.0000 |
| 622 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 623 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 624 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 625 |
HEPATIC FAILURE |
1 |
0.0000 |
| 626 |
EMOTIONAL DISTRESS |
4 |
0.0000 |
| 627 |
SUICIDE ATTEMPT |
2 |
0.0000 |
| 628 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 629 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 630 |
VOMITING |
15 |
0.0000 |
| 631 |
MIGRAINE |
3 |
0.0000 |
| 632 |
MOOD SWINGS |
1 |
0.0000 |
| 633 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 634 |
PRURITUS |
12 |
0.0000 |
| 635 |
INTENTIONAL OVERDOSE |
2 |
0.0000 |
| 636 |
NIGHT SWEATS |
1 |
0.0000 |
| 637 |
RHINORRHOEA |
2 |
0.0000 |
| 638 |
CONFUSIONAL STATE |
5 |
0.0000 |
| 639 |
DEPRESSION |
7 |
0.0000 |
| 640 |
AMNESIA |
2 |
0.0000 |
| 641 |
ALOPECIA |
6 |
0.0000 |
| 642 |
DYSPEPSIA |
3 |
0.0000 |
| 643 |
EYE DISORDER |
1 |
0.0000 |
| 644 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 645 |
HEART RATE INCREASED |
3 |
0.0000 |
| 646 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 647 |
FEBRILE NEUTROPENIA |
2 |
0.0000 |
| 648 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 649 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 650 |
LIP SWELLING |
1 |
0.0000 |
| 651 |
EYE PRURITUS |
1 |
0.0000 |
| 652 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 653 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 654 |
ANGER |
1 |
0.0000 |
| 655 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 656 |
HAEMATURIA |
1 |
0.0000 |
| 657 |
PYREXIA |
10 |
0.0000 |
| 658 |
DRUG INEFFECTIVE |
38 |
0.0000 |
| 659 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 660 |
HAEMORRHAGE |
3 |
0.0000 |
| 661 |
INJURY |
2 |
0.0000 |
| 662 |
HYPOXIA |
1 |
0.0000 |
| 663 |
SLEEP DISORDER |
2 |
0.0000 |
| 664 |
ANXIETY |
8 |
0.0000 |
| 665 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
5 |
0.0000 |
| 666 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 667 |
RESTLESSNESS |
1 |
0.0000 |
| 668 |
DYSURIA |
1 |
0.0000 |
| 669 |
DYSGEUSIA |
2 |
0.0000 |
| 670 |
HYPOAESTHESIA |
4 |
0.0000 |
| 671 |
ASTHENIA |
10 |
0.0000 |
| 672 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 673 |
ASTHMA |
3 |
0.0000 |
| 674 |
HOT FLUSH |
2 |
0.0000 |
| 675 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 676 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 677 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 678 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 679 |
DISORIENTATION |
1 |
0.0000 |
| 680 |
CARDIAC FAILURE |
2 |
0.0000 |
| 681 |
TREATMENT FAILURE |
2 |
0.0000 |
| 682 |
DRUG ABUSE |
2 |
0.0000 |
| 683 |
URTICARIA |
4 |
0.0000 |
| 684 |
MYALGIA |
4 |
0.0000 |
| 685 |
CONDITION AGGRAVATED |
7 |
0.0000 |
| 686 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 687 |
LIVER DISORDER |
1 |
0.0000 |
| 688 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 689 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 690 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 691 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 692 |
NO ADVERSE EVENT |
4 |
0.0000 |
| 693 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 694 |
VISION BLURRED |
3 |
0.0000 |
| 695 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 696 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 697 |
WEIGHT DECREASED |
6 |
0.0000 |
| 698 |
DYSPHAGIA |
2 |
0.0000 |
| 699 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 700 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 701 |
FEELING ABNORMAL |
5 |
0.0000 |
| 702 |
MALAISE |
9 |
0.0000 |
| 703 |
DRY EYE |
1 |
0.0000 |
| 704 |
AGGRESSION |
1 |
0.0000 |
| 705 |
FLUID RETENTION |
1 |
0.0000 |
| 706 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 707 |
ABDOMINAL PAIN UPPER |
4 |
0.0000 |
| 708 |
NERVOUSNESS |
1 |
0.0000 |
| 709 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 710 |
DEPRESSED MOOD |
1 |
0.0000 |
| 711 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 712 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 713 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 714 |
ARTHROPATHY |
1 |
0.0000 |
| 715 |
MEDICATION ERROR |
1 |
0.0000 |
| 716 |
FATIGUE |
14 |
0.0000 |
| 717 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 718 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 719 |
FLATULENCE |
1 |
0.0000 |
| 720 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 721 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 722 |
DYSPHONIA |
1 |
0.0000 |
| 723 |
BONE PAIN |
1 |
0.0000 |
| 724 |
CHILLS |
2 |
0.0000 |
| 725 |
IRRITABILITY |
1 |
0.0000 |
| 726 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 727 |
VERTIGO |
1 |
0.0000 |
| 728 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 729 |
CHEST PAIN |
3 |
0.0000 |
| 730 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 731 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 732 |
DIZZINESS |
8 |
0.0000 |
| 733 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 734 |
RENAL FAILURE |
2 |
0.0000 |
| 735 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 736 |
DRY SKIN |
2 |
0.0000 |
| 737 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 738 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 739 |
ARTHRALGIA |
6 |
0.0000 |
| 740 |
BURNING SENSATION |
1 |
0.0000 |
| 741 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 742 |
MOBILITY DECREASED |
1 |
0.0000 |
| 743 |
INJECTION SITE PAIN |
4 |
0.0000 |
| 744 |
PARAESTHESIA |
2 |
0.0000 |
| 745 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 746 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 747 |
DRUG DEPENDENCE |
2 |
0.0000 |
| 748 |
PROSTATE CANCER |
1 |
0.0000 |
| 749 |
DRY MOUTH |
1 |
0.0000 |
| 750 |
CARDIAC ARREST |
1 |
0.0000 |
| 751 |
TREMOR |
2 |
0.0000 |
| 752 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 753 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 754 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 755 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 756 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 757 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 758 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 759 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 760 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 761 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 762 |
SYNCOPE |
1 |
0.0000 |
| 763 |
HYPOTENSION |
2 |
0.0000 |
| 764 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 765 |
HYPERTENSION |
2 |
0.0000 |
| 766 |
DEATH |
8 |
0.0000 |
| 767 |
OVERDOSE |
2 |
0.0000 |
| 768 |
CONSTIPATION |
2 |
0.0000 |
| 769 |
FALL |
3 |
0.0000 |
| 770 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 771 |
PALPITATIONS |
1 |
0.0000 |
| 772 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 773 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 774 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 775 |
DIARRHOEA |
5 |
0.0000 |
| 776 |
NEUTROPENIA |
1 |
0.0000 |
| 777 |
COUGH |
2 |
0.0000 |
| 778 |
INFECTION |
1 |
0.0000 |
| 779 |
RASH |
3 |
0.0000 |
| 780 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 781 |
HOSPITALISATION |
1 |
0.0000 |
| 782 |
DRUG INTERACTION |
1 |
0.0000 |
| 783 |
COVID-19 |
1 |
0.0000 |
| 784 |
MUSCLE SPASMS |
1 |
0.0000 |
| 785 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 786 |
PNEUMONIA |
1 |
0.0000 |